Mumbai 400072, India
+91-90045 60540
info@omnisciencecapital.com

Tag: scientific investing

Science of Alpha from Safety

Sensex, Nifty still far from pre-COVID levels, but over 180 stocks have achieved the goal

Published in Moneycontrol Indian benchmark indices are at a 6-month high but are still 5 percent away from pre-COVID levels. The first case for COVID in India was registered on January 30. Sensex closed at 40,913 and Nifty50 ended at 12,035 that day. Read more about OmniScience Capital’s views on opportunities in Indian mid and smallcaps…
Read more

Is Mr. Market chasing the SuperNormal Portfolio?

India OmniView July 2020 Market has just begun unlocking the value in the ‘Unique’ SuperNormal portfolio Recently, Scientific Investing strategies have had a high absolute performance and outperformance relative to the benchmarks, as well as to other PMS or mutual fund managers. The performance has been broad-based across market caps and countries (US and India).…
Read more

Top 10 PMSes delivered double-digit returns in June, mid & smallcap schemes flavour of the month

Published in Moneycontrol Despite a series of rating downgrades, a deadly border clash with China and an alarming surge in COVID-19 cases, the market remained resilient in June rising, 7.66 percent on a month-on-month basis. … Asit C Mehta Ace Mulitcap took the third spot, with a month-on-month return of 16.4 percent … Read on…
Read more

Analysts overestimated corporate earnings in 8 out of last 10 years: Ambit

Published in Mint on 25 Jun 2020 The overestimation was at its worst in FY16 and FY17, resulting in a negative divergence of 24% and 25%, respectively. Two years, FY11 and FY19, also saw underestimation resulting in a positive divergence of 14% and 4%. Analysts in the country overestimated corporate earnings in eight out of…
Read more

A Scientific Investor’s Review Of The SuperNormal Portfolio

Dear Investors: In the previous OmniView we have discussed how the SuperNormal portfolio is created using the Scientific Investing approach. Further, we also provided the portfolio governance process during a time of crisis like the current times. In this OmniView we will introduce you to the key segments comprising the US OmniSupreme portfolio. This is…
Read more

Reports Of Gap’s Demise Are Highly Exaggerated, And Mr. Market’s Fears Have Mispriced The Stock

GPS management has shown clarity to survive through various possible scenarios of COVID-19 crisis. GPS management has the levers on cash expense management to navigate various scenarios. GPS likely will continue having significant cash flows from online sales, including BOPIS using curbside delivery. GPS is available at significant discounts to its intrinsic value under certain…
Read more

A FABLE OF FOUR FOLIOS

Indian Markets sliced using Occam’s Razor The belief currently in professional investment circles is that the Indian Stock Markets are highly overvalued and in a bubble. OmniScience Research takes a Scientific Investor’s approach and tries to dig deeper to understand if there is substance to this belief. Our analysis throws up large pockets of inefficiency…
Read more